FUROSEMIDE-AFT SOLUTION FOR INJECTION 20MG2ML

País: Singapur

Idioma: anglès

Font: HSA (Health Sciences Authority)

ingredients actius:

Furosemide

Disponible des:

APEX PHARMA MARKETING PTE. LTD.

Codi ATC:

C03CA01

formulario farmacéutico:

INJECTION, SOLUTION

Composición:

Furosemide 20mg/2ml

Vía de administración:

INTRAVENOUS, INTRAMUSCULAR

tipo de receta:

Prescription Only

Fabricat per:

Private Joint Stock Company "Pharmaceutical firm "Darnitsa"

Estat d'Autorització:

ACTIVE

Data d'autorització:

2023-05-16

Fitxa tècnica

PRODUCT INFORMATION – FUROSEMIDE – AFT (FUROSEMIDE) INJECTION
1
NAME OF THE MEDICINE
Furosemide
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Furosemide 20 mg/ 2 mL solution for injection. Contains 160 µmol/mL
of sodium.
Furosemide is an anthranilic acid derivative. Chemically, it is
4-chloro-N-furfuryl-5-
sulfamoylanthranilic acid.
For the full list of excipients, see 6.1 List of excipients
3
PHARMCEUTICAL FORM
Furosemide – AFT injection is a glass ampoule containing clear,
colourless or light
yellowish solution. The drug product has a pH of 8.0-9.3.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
•
Oedema due to cardiac and hepatic diseases (ascites)
•
Oedema
due
to
renal
disease
(in
the
nephrotic
syndrome,
therapy
of
the
underlying diseases has precedence)
•
Acute cardiac insufficiency, especially in pulmonary oedema
(administration in
conjunction with other therapeutic measures)
•
Reduced urinary output due to gestoses (pregnancy-related nephrosis),
after
restoring the fluid volume to normal
•
Supportive measures in brain oedema
•
Oedema due to burns
•
Hypertensive crisis (in addition to other antihypertensive measures)
•
To support forced diuresis in poisoning
4.2
DOSE AND METHOD OF ADMINISTRATION
ADULTS
Parenteral therapy with Furosemide – AFT should be used only in
patients unable to take
oral medication or in emergency situations and should be replaced with
oral therapy as
soon as practical. To achieve optimum efficacy and
suppress counter-regulation, a
continuous
furosemide
(frusemide)
infusion
is
generally
preferred
to
repeat
bolus
injections.
Intramuscular administration must be restricted to exceptional cases
where neither oral
nor intravenous administration are feasible. It must be noted that
intramuscular injection
is not suitable for the treatment of acute conditions such as
pulmonary oedema.
_OEDEMA _
The usual initial dose of Furosemide – AFT is 20 to 40 mg given as a
single dose, injected
intramuscularly or intravenously. The intravenous dose should be given
slowly (se